Northern Trust’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-51,414
Closed -$34K 4351
2019
Q1
$34K Hold
51,414
﹤0.01% 4081
2018
Q4
$23K Hold
51,414
﹤0.01% 4140
2018
Q3
$54K Sell
51,414
-19
-0% -$21 ﹤0.01% 4127
2018
Q2
$58K Buy
51,433
+8,494
+20% +$12.7K ﹤0.01% 4105
2018
Q1
$68K Sell
42,939
-123
-0.3% -$216 ﹤0.01% 4042
2017
Q4
$72K Buy
43,062
+3,174
+8% +$6.57K ﹤0.01% 4030
2017
Q3
$98K Hold
39,888
﹤0.01% 3960
2017
Q2
$150K Sell
39,888
-97,010
-71% -$331K ﹤0.01% 3882
2017
Q1
$365K Buy
136,898
+7,112
+5% +$18K ﹤0.01% 3615
2016
Q4
$289K Buy
129,786
+5,389
+4% +$15.8K ﹤0.01% 3664
2016
Q3
$439K Buy
124,397
+10,797
+10% +$49.5K ﹤0.01% 3542
2016
Q2
$1.52M Sell
113,600
-512
-0.4% -$8.51K ﹤0.01% 3176
2016
Q1
$1.83M Buy
114,112
+2,031
+2% +$27.8K ﹤0.01% 3040
2015
Q4
$1.78M Sell
112,081
-306
-0.3% -$5.25K ﹤0.01% 3117
2015
Q3
$1.6M Buy
112,387
+22,942
+26% +$389K ﹤0.01% 3159
2015
Q2
$2M Sell
89,445
-3,249
-4% -$81.3K ﹤0.01% 3063
2015
Q1
$1.87M Buy
92,694
+214
+0.2% +$3.98K ﹤0.01% 3163
2014
Q4
$1.52M Sell
92,480
-2,321
-2% -$36.2K ﹤0.01% 3246
2014
Q3
$1.45M Buy
94,801
+72,185
+319% +$1.43M ﹤0.01% 3284
2014
Q2
$568K Buy
22,616
+9,486
+72% +$216K ﹤0.01% 3564
2014
Q1
$275K Buy
13,130
+2,573
+24% +$91.3K ﹤0.01% 3707
2013
Q4
$397K Buy
10,557
+3,540
+50% +$64.5K ﹤0.01% 3553
2013
Q3
$136K Buy
7,017
+387
+6% +$5.71K ﹤0.01% 3750
2013
Q2
$80K Buy
+6,630
New +$97.8K ﹤0.01% 3844

Other funds holding CYTR

Northern Trust's CYTR Position: Q2 2019 in Review

Northern Trust sold out of CytRx Corp (CYTR) in Q2 2019, closing a stake of 51,414 shares — an estimated $34K sold.

Northern Trust first reported a position in CYTR in Q2 2013 and held it in 24 quarters. The position peaked at $2M in Q2 2015. 5 funds tracked by Wall St. Rank hold CYTR as of Q2 2019.

  • Northern Trust reported no remaining CytRx Corp position as of Q2 2019 after selling out during the quarter.
  • Northern Trust sold 51,414 CytRx Corp shares in Q2 2019, an estimated $34K.
  • Northern Trust first reported a position in CytRx Corp in Q2 2013 and held it in 24 quarters.
  • Northern Trust's CytRx Corp position peaked at $2M in Q2 2015.
  • 5 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2019.

Based on Northern Trust's 13F filing for Q2 2019, filed 13 Aug 2019.